drugset / Trial / NCT01479296
Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate the immune response to the Vaccine Research Center (VRC) rAd5 HIV vaccine when the vaccine components are administered in three different ways, in healthy, HIV-uninfected adults.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-05
- Completion
- 2017-11-27
Publications
- Background Appay V, Douek DC, Price DA. CD8+ T cell efficacy in vaccination and disease. Nat Med. 2008 Jun;14(6):623-8. doi: 10.1038/nm.f.1774.
- Background Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D. Memory CD8 T-cell compartment grows in size with immunological experience. Nature. 2009 Jan 8;457(7226):196-9. doi: 10.1038/nature07486. Epub 2008 Nov 12.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VRC rAd5 vaccine | Vaccine | 2.5e+09 unknown | Intramuscular |
| Subject | VRC rAd5 vaccine | Vaccine | 1e+10 unknown | Intramuscular |
| Subject | rAd5 Env A | Vaccine | 1.7e+09 unknown | Intramuscular |
| Subject | rAd5 Env B | Vaccine | 1.7e+09 unknown | Intramuscular |
| Subject | rAd5 Gag-Pol | Unknown | 5e+09 unknown | Intramuscular |
| Subject | rAd5 env C | Unknown | 1.7e+09 unknown | Intramuscular |